Literature DB >> 25088113

Radioguided surgery in patient with pancreatic neuroendocrine tumour followed by PET/CT scan as a new approach of complete resection evaluation--case report.

Jolanta Kunikowska1, Maciej Słodkowski, Łukasz Koperski, Anna Kolasa, Jan Maryański, Piotr Pawliszak, Renata Matyskiel, Marek Chojnowski, Michał Najdzik, Leszek Królicki.   

Abstract

Radioguided surgery using 68-gallium labelled somatostatin analogues is a promising method for detection of small, intra-abdominal, neuroendocrine neoplasm (NEN). However, due to high background activity (physiological uptake in e.g. spleen, adrenal glands and kidneys) tumours of the tail and body of pancreas might be impossible to detect with hand-held gamma probe. Therefore a new concept of intraoperative PET/CT scan of the resected tissue can be helpful in determining whether the tumour has been excised within the margins of healthy tissue. A 71-year-old woman with primary, non-metastatic NEN of the tail of pancreas is described. The tumour was diagnosed using MRI and PET/CT scan. Before operation patient was administered intravenously 80 MBq of ⁶⁸Ga-DOTATATE. The surgery procedure was performed 60-180 minutes post injection. During the procedure pancreas was visualized, but the tumour could not be localized neither with palpation nor gamma probe. The tail of the pancreas was resected en bloc with spleen and adjacent lymph nodes. PET/CT scan of the tissue specimen was performed immediately followed by pathological examination. PET/CT scan of the resected tissue showed moderate activity in the tail of pancreas, and a small focus of high activity in the tail. Area of high SSTR expression in the tail corresponded with preoperative findings in MRI and whole-body PET/CT. Histopathological examination of the specimen confirmed the presence of neuroendocrine tumour grade 1. Immediate PET/CT scan of the surgical specimen can bring new quality to intraoperative assessment of completeness of resection of neuroendocrine tumours.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25088113     DOI: 10.5603/NMR.2014.0028

Source DB:  PubMed          Journal:  Nucl Med Rev Cent East Eur        ISSN: 1506-9680


  3 in total

1.  Feasibility of Radio-Guided Surgery with ⁶⁸Gallium-DOTATATE in Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumors.

Authors:  Samira M Sadowski; Corina Millo; Vladimir Neychev; Rachel Aufforth; Xavier Keutgen; Joanne Glanville; Meghna Alimchandani; Naris Nilubol; Peter Herscovitch; Martha Quezado; Electron Kebebew
Journal:  Ann Surg Oncol       Date:  2015-09-08       Impact factor: 5.344

Review 2.  Imaging of pancreatic neuroendocrine tumors: recent advances, current status, and controversies.

Authors:  Lingaku Lee; Tetsuhide Ito; Robert T Jensen
Journal:  Expert Rev Anticancer Ther       Date:  2018-07-17       Impact factor: 4.512

Review 3.  Radioguided Surgery for Gastroenteropancreatic Neuroendocrine Tumours: a Systematic Literature Review.

Authors:  Katrina Clair Cockburn; Zaher Toumi; Alison Mackie; Peter Julyan
Journal:  J Gastrointest Surg       Date:  2021-09-10       Impact factor: 3.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.